107 related articles for article (PubMed ID: 6196769)
21. [Alpha fetoprotein in childhood neoplasms].
Woźniak W; Duchnowska A; Czerwiński W; Ordyniec J
Pediatr Pol; 1979 Aug; 54(8):847-52. PubMed ID: 92007
[No Abstract] [Full Text] [Related]
22. Evaluation of population screening for hepatocellular carcinoma.
Tang ZY; Yang BH; Tang CL; Yu YQ; Lin ZY; Weng HZ
Chin Med J (Engl); 1980 Nov; 93(11):795-9. PubMed ID: 6159140
[No Abstract] [Full Text] [Related]
23. Diamminodichloride platinum (cis-platinum) in the treatment of hepatocellular carcinoma.
Melia WM; Westaby D; Williams R
Clin Oncol; 1981 Dec; 7(4):275-80. PubMed ID: 6172230
[No Abstract] [Full Text] [Related]
24. A study of hepatitis Bs antigen titres and alpha foetoprotein levels in primary hepatocellular carcinoma in Kenya.
Bowry TR; Shah MV
East Afr Med J; 1980 Jun; 57(6):382--9. PubMed ID: 6156817
[No Abstract] [Full Text] [Related]
25. Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis.
Kuwahara T; Sakai T; Majima Y; Hirai K; Tanikawa K
Hepatogastroenterology; 1993 Aug; 40(4):347-51. PubMed ID: 7691701
[TBL] [Abstract][Full Text] [Related]
26. Surgical treatment of small primary liver carcinoma.
Li GH; Li JQ; Zhan YQ
Chin Med J (Engl); 1986 Oct; 99(10):827-8. PubMed ID: 2433102
[No Abstract] [Full Text] [Related]
27. Prognostic factors after hepatectomy for hepatocellular carcinoma.
Chou FF; Sheen-Chen SM; Chen CL; Chen YS; Chen MJ
Hepatogastroenterology; 1994 Oct; 41(5):419-23. PubMed ID: 7531666
[TBL] [Abstract][Full Text] [Related]
28. Clinico-cytopathological spectrum of hepatocellular carcinoma, its correlation with serum alpha-fetoprotein level, and hepatitis B and C viral markers.
Radhika NS; Duseja A; Rajwanshi A; Gupta SK; Sehgal S; Suri S; Chawla Y
Trop Gastroenterol; 2004; 25(3):116-20. PubMed ID: 15682657
[TBL] [Abstract][Full Text] [Related]
29. [Detection of alpha-fetoproteins mRNA and melanoma antigen-1 mRNA in peripheral blood of patients with hepatocellular carcinoma and its clinical significance].
Yang SZ; Dong JH; Zhu J; Li K; Zhang Y
Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(17):1060-3. PubMed ID: 15498320
[TBL] [Abstract][Full Text] [Related]
30. Comparison of alpha-fetoprotein with some other tumour markers in Malaysians with hepatocellular carcinoma.
Lopez JB; Balasegaram M; Timor J; Thambyrajah V
Malays J Pathol; 1997 Jun; 19(1):53-8. PubMed ID: 10879242
[TBL] [Abstract][Full Text] [Related]
31. Fibrolamellar carcinoma of the liver with a mixture of ordinary hepatocellular carcinoma: a case report.
Okano A; Hajiro K; Takakuwa H; Kobashi Y
Am J Gastroenterol; 1998 Jul; 93(7):1144-5. PubMed ID: 9672347
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey.
Ozer B; Serin E; Yilmaz U; Gümürdülü Y; Saygili OB; Kayaselçuk F; Boyacioğlu S
Turk J Gastroenterol; 2003 Jun; 14(2):85-90. PubMed ID: 14614632
[TBL] [Abstract][Full Text] [Related]
33. Hepatocellular carcinoma with striking rosette-like structures on smears.
Schreiner AM; Yang GC
Diagn Cytopathol; 2012 Nov; 40(11):991-2. PubMed ID: 22021069
[No Abstract] [Full Text] [Related]
34. Clinicopathological features of hepatocellular carcinoma--comparison of hepatitis B seropositive and seronegative patients.
Okuda H; Obata H; Motoike Y; Hisamitsu T
Hepatogastroenterology; 1984 Apr; 31(2):64-8. PubMed ID: 6202615
[TBL] [Abstract][Full Text] [Related]
35. An analysis of the UNOS liver transplant registry: high serum alpha-fetoprotein does not justify an increase in MELD points for suspected hepatocellular carcinoma.
Kemmer N; Neff G; Kaiser T; Zacharias V; Thomas M; Tevar A; Satwah S; Shukla R; Buell J
Liver Transpl; 2006 Oct; 12(10):1519-22. PubMed ID: 17004260
[TBL] [Abstract][Full Text] [Related]
36. Alphafetoprotein levels measured by radioimmunoassay in various liver malignancies.
Chang FY; Chen TC; Fong MS; Lin S; Yeh SH
Taiwan Yi Xue Hui Za Zhi; 1982 Feb; 81(2):224-31. PubMed ID: 6178794
[No Abstract] [Full Text] [Related]
37. [Clinical significance of AFP-L3 variants determined by micro centrifugal column].
Wang YZ; Luo LB; Wu GX; Chen M; Ruan LH; Pu XK; Hang SR
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Jun; 21(2):135-7. PubMed ID: 17653315
[TBL] [Abstract][Full Text] [Related]
38. Hepatocellular carcinoma of diffuse type: MR imaging findings and clinical manifestations.
Kanematsu M; Semelka RC; Leonardou P; Mastropasqua M; Lee JK
J Magn Reson Imaging; 2003 Aug; 18(2):189-95. PubMed ID: 12884331
[TBL] [Abstract][Full Text] [Related]
39. Fibrolamellar hepatocellular carcinoma with a recurrence of classic hepatocellular carcinoma: a case report and review of Oriental cases.
Chang YC; Dai YC; Chow NH
Hepatogastroenterology; 2003; 50(53):1637-40. PubMed ID: 14571804
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological differences between hepatitis B viral genotype B- and C-related resectable hepatocellular carcinoma.
Lin CL; Chen JD; Liu CJ; Lee PH; Chen PJ; Lai MY; Kao JH; Chen DS
J Viral Hepat; 2007 Jan; 14(1):64-9. PubMed ID: 17212646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
